1. Home
  2. RDY vs BBU Comparison

RDY vs BBU Comparison

Compare RDY & BBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • BBU
  • Stock Information
  • Founded
  • RDY 1984
  • BBU 2016
  • Country
  • RDY India
  • BBU Bermuda
  • Employees
  • RDY N/A
  • BBU N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • BBU Engineering & Construction
  • Sector
  • RDY Health Care
  • BBU Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • BBU Nasdaq
  • Market Cap
  • RDY 2.1B
  • BBU 2.3B
  • IPO Year
  • RDY N/A
  • BBU N/A
  • Fundamental
  • Price
  • RDY $14.60
  • BBU $25.79
  • Analyst Decision
  • RDY Strong Buy
  • BBU Buy
  • Analyst Count
  • RDY 2
  • BBU 6
  • Target Price
  • RDY $16.95
  • BBU $31.33
  • AVG Volume (30 Days)
  • RDY 1.4M
  • BBU 12.9K
  • Earning Date
  • RDY 07-28-2025
  • BBU 08-01-2025
  • Dividend Yield
  • RDY 0.56%
  • BBU 0.97%
  • EPS Growth
  • RDY 1.47
  • BBU N/A
  • EPS
  • RDY 0.79
  • BBU N/A
  • Revenue
  • RDY $3,809,801,863.00
  • BBU $35,354,000,000.00
  • Revenue This Year
  • RDY $10.24
  • BBU N/A
  • Revenue Next Year
  • RDY N/A
  • BBU N/A
  • P/E Ratio
  • RDY $18.44
  • BBU N/A
  • Revenue Growth
  • RDY 16.61
  • BBU N/A
  • 52 Week Low
  • RDY $12.26
  • BBU $18.45
  • 52 Week High
  • RDY $16.89
  • BBU $27.47
  • Technical
  • Relative Strength Index (RSI)
  • RDY 42.74
  • BBU 55.26
  • Support Level
  • RDY $14.46
  • BBU $25.32
  • Resistance Level
  • RDY $15.25
  • BBU $26.52
  • Average True Range (ATR)
  • RDY 0.18
  • BBU 0.80
  • MACD
  • RDY -0.10
  • BBU -0.08
  • Stochastic Oscillator
  • RDY 16.40
  • BBU 45.29

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

Share on Social Networks: